Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Finders Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Finders Agreement

Entities:

RepliGen Corp.; Paramount Capital, Inc.

Date:

2000

Size:

Preview shows 3KB of 23KB total

Price:

$44

ID:

#116315

 

 

► Fee Agreements ► Finders Agreements
► Biotech & Drugs ► Biological Products

 

 

Start of Preview




March 2, 2000

Walter C. Herlihy, Ph.D.
Chief Executive Officer
Repligen Corporation
117 Fourth Avenue
Needham, MA 02494

FINDERS AGREEMENT

Dear Sirs:

Reference is made to our recent discussions relating to a proposed
private placement under Rule 506 of Regulation D of the Securities Act of 1933,
as amended (the "Act") of securities of Repligen Corp. (the "Company") as
hereinafter described. Based upon our discussions and representations which you
have made to us describing the Company and its principals, the present and
proposed business activities of the Company and the Company's operations and
financial condition, Paramount Capital, Inc. ("Paramount") hereby confirms in
principle its interest in acting as a finder for the Company, on a "best
efforts" basis, in connection with the private placement offering of the
Company's shares of Common Stock (the "Offering"), upon the following basic
terms and conditions:

1. Paramount will introduce the Company to "accredited investors" as
defined in Rule 501 of Regulation D promulgated under the Act for the purchase
of up to 2,650,000 shares of common stock, par value $.01 per share (the "Common
Stock"). Each share of Common Stock will be sold at a price per share price (the
"Per Share Price") equal to eighty five percent (85%) of the average closing bid
price of the Common Stock for the fifteen (15) trading days immediately
preceding the Closing Date (as defined in paragraph 2 below) of the Offering;
provided, however, that in no event will the Per Share Price be greater than
$8.625. Further, subject to the Break-up Fee (as defined in paragraph 20 below)
the Company shall not be required to sell the Common Stock at a Price Per Share
less than $6.00. For purposes hereof, "closing bid price" shall mean, for each
trading day, the price at which the Common Stock was last exchanged on the
Nasdaq National Market during such trading day, or, if there were no
transactions on such trading day, the average of the reported closing bid and
asked prices, regular way, of the Common Stock on such trading day. "Trading
day" shall mean a day on which the relevant Nasdaq National Market is open for
the transaction of business.

2. The closing date of the Offering will occur no later than sixty (60)
days following the execution of this Agreement, subject to extension at the
option of the Company for an additional thirty (30) days (the date of any such

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC